Exploring the Association Between Vitamin D and IL-10 in Allergic Parthenium Contact Dermatitis Patients
- PMID: 40630332
- PMCID: PMC12234820
- DOI: 10.7759/cureus.85515
Exploring the Association Between Vitamin D and IL-10 in Allergic Parthenium Contact Dermatitis Patients
Abstract
Introduction The imbalance between pro- and anti-inflammatory mediators was suggested to be a contributory factor to the manifestations of allergic parthenium dermatitis. Inadequate circulating vitamin D and IL-10 levels can significantly influence the course of this allergic dermatitis. Objective The objective was to study the association between circulating IL-10 levels and vitamin D status in patients with parthenium dermatitis. Materials and methods Patients attending the dermatitis clinic were screened for eligibility, and 88 individuals were recruited. A total of 101 unrelated healthy volunteers were included as controls. Circulating IL-10 cytokine and vitamin D levels were determined in both groups and compared. Results A higher prevalence of vitamin D deficiency (79.5% vs. 59.4%, P = 0.000315) and lower IL-10 levels (6.84 vs. 9.04 pg/ml, P < 0.0001) were observed in the patient group compared to healthy controls. The vitamin D-deficient patients were also found to have significantly lower IL-10 levels. A significant positive correlation between vitamin D and IL-10 levels was observed among individuals with allergic dermatitis. Lower vitamin D and IL-10 levels were associated with higher Dermatology Life Quality Index (DLQI) scores. Conclusion Lower circulating vitamin D and IL-10 levels, observed in patients with parthenium dermatitis, significantly impacted their quality of life. Assessing plasma IL-10 levels could be a potential biomarker for evaluating disease severity and treatment efficacy. Correcting vitamin D deficiency may improve IL-10 levels and enhance treatment outcomes.
Keywords: allergy; anti-inflammatory cytokine; eczema; parthenium dermatitis; sunshine vitamin.
Copyright © 2025, Xavier et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Ethics Committee for Human Studies (Reg. No. ECR/342/Inst/PY/2013), JIPMER, Puducherry issued approval JIP/IEC/2015/20/725. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Airborne contact dermatitis induced by parthenium: a study of 50 cases in South India. Agarwal KK, D'Souza M. Clin Exp Dermatol. 2009;34:0–6. - PubMed
-
- Parthenium dermatitis caused by immediate and delayed hypersensitivity. Lakshmi C, Srinivas CR. Contact Dermatitis. 2007;57:64–65. - PubMed
-
- Parthenium: a wide angle view. Lakshmi C, Srinivas CR. Indian J Dermatol Venereol Leprol. 2007;73:296–306. - PubMed
-
- Parthenium dermatitis in India: past, present and future. Sharma VK, Verma P. Indian J Dermatol Venereol Leprol. 2012;78:560–568. - PubMed
LinkOut - more resources
Full Text Sources